作者
Matthew J Labreche, Grace C Lee, Russell T Attridge, Eric M Mortensen, Jim Koeller, Liem C Du, Natalie R Nyren, Lucina B Treviño, Sylvia B Treviño, Joel Peña, Michael W Mann, Abilio Muñoz, Yolanda Marcos, Guillermo Rocha, Stella Koretsky, Sandra Esparza, Mitchell Finnie, Steven D Dallas, Michael L Parchman, Christopher R Frei
发表日期
2013/9/1
期刊
The Journal of the American Board of Family Medicine
卷号
26
期号
5
页码范围
508-517
出版商
American Board of Family Medicine
简介
Objective
To measure the incidence of treatment failure and associated costs in patients with methicillin-resistant Staphylococcus aureus skin and soft tissue infections (SSTIs).
Methods
This was a prospective, observational study in 13 primary care clinics. Primary care providers collected clinical data, wound swabs, and 90-day follow-up information. Patients were considered to have “moderate or complicated” SSTIs if they had a lesion≥ 5 cm in diameter or diabetes mellitus. Treatment failure was evaluated within 90 days of the initial visit. Cost estimates were obtained from federal sources.
Results
Overall, treatment failure occurred in 21% of patients (21 of 98) at a mean additional cost of 1,933.71perpatient.Inasubgroupanalysisofpatientswhoreceivedincisionanddrainage,thosewithmoderateorcomplicatedSSTIshadhigherratesoftreatmentfailurethanthosewithmildoruncomplicatedSSTIs(36%vs.10%;P=.04 …
引用总数
20132014201520162017201820192020202120222023161199787546